RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5593
Malaria parasiteP. berghei
Genotype
Transgene
Transgene not Plasmodium: P. falciparum CSP (PF3D7_0304600) fused to OVA
Promoter: Gene model: Not available; Gene model (P.falciparum): Not available; Gene product: Not available
3'UTR: Gene model: Not available; Gene product: Not available
Phenotype Sporozoite; Liver stage;
Last modified: 22 January 2025, 15:18
  *RMgm-5593
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Introduction of a transgene
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherGao X, Cockburn IA
Name Group/DepartmentDivision of Immunology and Infectious Disease, John Curtin School of Medical Research
Name InstituteThe 8 Australian National University
CityCanberra
CountryAustralia
Name of the mutant parasite
RMgm numberRMgm-5593
Principal namePfCSP-OVA(surface); PfCSP-OVA(fusion)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
Sporozoitesee below
Liver stageSee below
Additional remarks phenotype

Mutant/mutation
Three mutant are described that express CSP from P. falciparum (PF3D7_0304600) fused to Ovalbumin (OVA).
No detailed description is provided of the generation of DNA constructs and the generation of the mutants. It seems likely that the PfCSP-OVA transgenes are introduced in mutants PfCSP-OVA(surface) and PfCSP-OVA(fusion) as an additional copy under the control of the promoter of the sporozoite/liver stage specific  UIS4 gene

We generated three lines of transgenic parasites co-expressing PfCSP (PF3D7_0304600) and the OVA323-339 (OT-II epitope) in different relative spatial locations. First, PfCSP-OVAcytosol contained PfCSP on the surface of the SPZ and OVA (whole protein, fused with mCherry) expressed cytosolically under the control of a strong constitutive promoter Hsp70.
Second, PfCSP-OVAsurface carried intact PfCSP, and PbCSP molecule with OVA260-386 inserted between the repeat and C terminus in order to target OVA to the sporozoite surface but on a separate protein.
Third, PfCSP-OVAfusion carried OVA260-386 inserted between the repeat and C-terminus of PfCSP. Since the insertion of the OVA260-386 rendered PfCSP non-functional it was also necessary to insert PbCSP to ensure SPZs can still emerge from mosquitoes

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2024.08.10.607257

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
In previous experiments, different transgenic T cells might have intrinsically different capacity to help B cells (e.g. different TCR affinity). To address this limitation, we generated three lines of transgenic parasites co-expressing PfCSP (PF3D7_0304600) and the OVA323-339 (OT-II epitope) in different relative spatial locations. First, PfCSP-OVAcytosol contained PfCSP on the surface of the SPZ and OVA (whole protein, fused with mCherry) expressed cytosolically under the control of a strong constitutive promoter Hsp70.
Second, PfCSP-OVAsurface carried intact PfCSP, and PbCSP molecule with OVA260-386 inserted between the repeat and C terminus in order to target OVA to the sporozoite surface but on a separate protein.
Third, PfCSP-OVAfusion carried OVA260-386 inserted between the repeat and C-terminus of PfCSP. Since the insertion of the OVA260-386 rendered PfCSP non-functional it was also necessary to insert PbCSP to ensure SPZs can still emerge from mosquitoes.

Mice were immunizated by intravenous injection with 3-6 ×104 irradiated (15kRad) sporozoites of the three different mutant parasites.
Analysis of immunized mice with these mutant parasites showed that Ighg2A10 B cells can receive help from CD4+ T cells that are specific for bystander surface, but not cytosolic SPZ antigens.


Additional information

Other mutants


  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameP. falciparum CSP (PF3D7_0304600) fused to OVA
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructunknown
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitepyrimethamine resistant dhfr gene
Promoter of the selectable markerunknown
Selection (positive) procedureunknown
Selection (negative) procedureNo
Additional remarks genetic modificationNo detailed description is provided of the generation of DNA constructs and the generation of the mutants.
It seems likely that the PfCSP-OVA transgenes are introduced in mutant PfCSP-OVAsurface and PfCSP-OVAfusion as an additional copy under the control of the promoter of the sporozoite/liver stage specific UIS4 gene

We generated three lines of transgenic parasites co-expressing PfCSP and the OVA323-339 (OT-II epitope) in different relative spatial locations. First, PfCSP-OVAcytosol contained PfCSP on the surface of the SPZ and OVA (whole protein, fused with mCherry) expressed cytosolically under the control of a strong constitutive promoter Hsp70.
Second, PfCSP-OVAsurface carried intact PfCSP, and PbCSP molecule with OVA260-386 inserted between the repeat and C terminus in order to target OVA to the sporozoite surface but on a separate protein.
Third, PfCSP-OVAfusion carried OVA260-386 inserted between the repeat and C-terminus of PfCSP. Since the insertion of the OVA260-386 rendered PfCSP non-functional it was also necessary to insert PbCSP to ensure SPZs can still emerge from mosquitoes

The method to generate transgenic parasite was reported previously. The designed DNA sequences were ligated into the Pb268 plasmid which contains the homologous arms of the P. berghei chromosome 12, CSP promoter (followed by designed sequences) and DHFR gene (pyrimethamine resistance) under eEF1 promoter. The resulting plasmids were expanded in E. coli culture, miniprepped and digested overnight at 37°C by PvuI.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite Not available
Gene Model P. falciparum ortholog Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionNot available
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4